吲哚菁绿荧光导航对比常规腹腔镜肝切除治疗肝细胞癌:系统综述与Meta分析
该系统综述与Meta分析纳入17篇文献(4项随机对照试验和13项病例对照研究,共1620例患者),对比吲哚菁绿(ICG)荧光导航腹腔镜肝切除与非荧光腹腔镜肝切除治疗肝细胞癌的效果。结果显示,ICG荧光导航可缩短手术时间、减少术中出血和输血率、提高R0切除率并降低术后并发症率,但术后住院时间无统计学差异。
要点
- ICG荧光导航可缩短肝细胞癌腹腔镜肝切除的手术时间并减少术中出血。
- ICG荧光导航可提高R0切除率并降低术后并发症率。
- 两组术后住院时间无统计学显著差异。
核心结论
- 在肝细胞癌治疗中,吲哚菁绿荧光导航引导的肝切除术显示出更优的疗效与安全性,值得应用和推广。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA声明,PROSPERO注册号CRD42024532356。
- 检索CNKI、万方、PubMed、Embase、Cochrane Library和Web of Science,时间范围为1990年1月1日至2024年4月30日。
- 最终纳入17篇文献,包括4项随机对照试验和13项病例对照研究,共1620例患者;荧光腹腔镜组743例,非荧光腹腔镜组877例。
主要发现
- ICG荧光导航组手术时间显著缩短(MD = - 23.25,95% CI:- 36.35至- 10.15,P = 0.0005)。
- ICG荧光导航组术中出血量显著减少(MD = - 51.04,95% CI:- 69.52至- 32.56,P < 0.00001)。
- ICG荧光导航组术中输血率显著降低(OR = 0.43,95% CI:0.27至0.69,P = 0.0004)。
- ICG荧光导航组R0切除率显著提高(OR = 2.93,95% CI:1.73至4.96,P < 0.0001),术后并发症率显著降低(OR = 0.59,95% CI:0.43至0.82,P = 0.002)。
- 两组术后住院时间无统计学显著差异(MD = - 0.67,95% CI:- 1.51至0.18,P = 0.12)。
临床怎么用
- 对于肝细胞癌行腹腔镜肝切除的患者,可考虑采用ICG荧光导航以缩短手术时间、减少出血、提高R0切除率并降低术后并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indocyanine green (ICG) fluorescence imaging technology is increasingly widely used in laparoscopic hepatectomy. However, previous studies have produced conflicting results regarding whether it is truly superior to traditional laparoscopic hepatectomy. This study investigated the clinical effect of laparoscopic hepatectomy for hepatocellular carcinoma (HCC) using ICG imaging technology. METHODS: A systematic review and meta-analysis, based on the preferred reporting items for systematic reviews and meta-analysis statement, were conducted (PROSPERO: CRD42024532356). A computer search was conducted in databases including CNKI, Wanfang, PubMed, Embase, Cochrane Library, and Web of Science from January 1, 1990, to April 30, 2024. RESULTS: A total of 17 articles were included after screening, comprising 4 randomized controlled trials and 13 case-control studies, with 1620 patients in total. Among these, there were 743 cases in the fluorescence laparoscopy group and 877 cases in the non-fluorescence laparoscopy group. Hepatectomy guided by indocyanine green fluorescence navigation significantly reduced operation time (MD = - 23.25, 95% CI: - 36.35 to - 10.15, P = 0.0005), intraoperative blood loss (MD = - 51.04, 95% CI: - 69.52 to - 32.56, P < 0.00001), and intraoperative transfusion rate (OR = 0.43, 95% CI: 0.27 to 0.69, P = 0.0004), while increasing the R0 resection rate (OR = 2.93, 95% CI: 1.73 to 4.96, P < 0.0001) and decreasing the postoperative complication rate (OR = 0.59, 95% CI: 0.43 to 0.82, P = 0.002). However, there was no statistically significant difference in postoperative length of hospital stay (MD = - 0.67, 95% CI: - 1.51 to 0.18, P = 0.12). CONCLUSION: In the treatment of HCC, hepatectomy guided by indocyanine green fluorescence navigation demonstrates superior efficacy and safety, its application and promotion are warranted.
引用
- Hu M, Chen Z, Xu D, et al. Efficacy and safety of indocyanine green fluorescence navigation versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. Surg Endosc. 2025. PMID: 39806179. doi:10.1007/s00464-024-11518-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。